COVID-19 and angiotensin-converting enzyme inhibitors from plant origin.
10.1016/j.joim.2022.06.005
- Author:
Reza GHAREBAGHI
1
;
Fatemeh HEIDARY
2
Author Information
1. International Virtual Ophthalmic Research Center, Austin, TX 78731, United States.
2. International Virtual Ophthalmic Research Center, Austin, TX 78731, United States. Electronic address: drfatemehheidari@yahoo.com.
- Publication Type:Letter
- MeSH:
Angiotensin-Converting Enzyme Inhibitors/therapeutic use*;
COVID-19/drug therapy*;
Humans;
Hypertension;
SARS-CoV-2
- From:
Journal of Integrative Medicine
2022;20(5):476-476
- CountryChina
- Language:English
